Skip to main content
. 2014 Mar 27;9(6):1049–1058. doi: 10.2215/CJN.07870713

Figure 2.

Figure 2.

Fibroblast growth factor (FGF)-23 is predictive for (A) atherosclerotic events/death and (B) decompensated heart failure/death in univariate analysis. Patients were stratified into tertiles by their plasma FGF-23 levels (Kaplan–Meier analysis with log-rank test).

HHS Vulnerability Disclosure